Fulgent Genetics (NASDAQ:FLGT) reported its Q1 earnings results on Friday, May 5, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Fulgent Genetics beat estimated earnings by 48.84%, reporting an EPS of $-0.22 versus an estimate of $-0.43.
Revenue was down $254.10 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 2.87% drop in the share price the next day.
Here’s a look at Fulgent Genetics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | 0.05 | 0.73 | 3.86 |
| EPS Actual | -0.48 | 0.32 | 0.78 | 5.08 |
| Revenue Estimate | 59.57M | 91.36M | 122.70M | 270.85M |
| Revenue Actual | 67.70M | 105.66M | 125.34M | 320.27M |
To track all earnings releases for Fulgent Genetics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
